Document:

Exhibit 4.2

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

CREATIVE REALITIES, INC.

 

	Warrant Shares: 1,400,000	 	Initial Exercise Date: August 17, 2022

 

Issue Date: February 17, 2022

 

THIS COMMON STOCK PURCHASE WARRANT
(the “Warrant”) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
August 16, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 16, 2027
(the “Termination Date”), but not thereafter, to subscribe for and purchase from Creative Realities, Inc., a Minnesota
corporation (the “Company”), up to 1,400,000 shares of the Company’s common stock, par value $0.01 per share
(the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”).

 

Section 1. Definitions.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Securities Purchase Agreement, dated
as of February 3, 2022, by and between the Company, the Holder and other purchasers signatory thereto (as may be amended, amended and
restated, supplemented or otherwise modified from time to time in accordance with its terms, the “Purchase Agreement”).

 

Section 2. Exercise.

 

a) Exercise
of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto, and delivered in
accordance with the notice requirements set forth in Section 5(h) (the “Notice of Exercise”). Within the earlier
of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant
Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice
of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been
exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in
purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder
and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company
shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. Notwithstanding the
foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Date
prior to the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the
Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise
Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the
aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date. The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph,
following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof. “Business Day” means any day other
than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain
closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law
to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York
generally are open for use by customers on such day.

 

    1

     

    

 

b) Exercise
Price. The exercise price per share of Common Stock under this Warrant shall be $1.41 subject to adjustment hereunder (the “Exercise
Price”).

 

c) Cashless
Exercise. If after the Issue Date there is no effective registration statement registering, or the prospectus contained therein is
not available for the resale of the Warrant Shares, then this Warrant may also be exercised, in whole or in part, at such time by means
of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares determined according
to the following formula:

 

Net Number = (A x B) - (A x C) 

       B

 

For purposes of the foregoing formula:

 

(A) =
the total number of Warrant Shares with respect to which this Warrant is then being exercised if such exercise were by means of a cash
exercise rather than a cashless exercise.

 

(B) =
as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise
is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the
VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the shares of Common
Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution of the applicable Notice
of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within
two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant
to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a
Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular
trading hours” on such Trading Day; and

 

(C) =
the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

If Warrant Shares are
issued in such a cashless exercise, the parties hereto acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and for purposes of Rule 144
of the Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant.
The Company agrees not to take any position contrary to this Section 2(c). Notwithstanding anything to the contrary, without
limiting the rights of the Holder to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein and the right of
the Holder to exercise this Warrant on a “cashless exercise” pursuant to this Section 2(c), in the event the Company
does not have or maintain an effective registration statement, there are no circumstances that would require the Company to make any
cash payments or net cash settle the purchase warrants to the holders.

 

    2

     

    

 

“Bid Price”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the bid price of the shares of Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)
if the shares of Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Trading Day” means a day on
which the principal Trading Market is open for trading.

 

“Trading Market”
means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading on the date in question:
the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange,
OTCQB or OTCQX (or any successors to any of the foregoing).

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the shares of Common Stock are then
listed or quoted on a Trading Market, the daily volume weighted average price of the shares of Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the shares of Common Stock are then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the shares of Common Stock are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock
are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.

 

Notwithstanding anything herein
to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section
2(c).

 

    3

     

    

 

d) Mechanics of Exercise.

 

i. Delivery
of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a
participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or
manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants and subject to receipt from the Holder
by the Company and the Transfer Agent of customary representations reasonably acceptable to the Company and the Transfer Agent in
connection with such request), and otherwise by physical delivery of a certificate (or an account statement reflecting unrestricted
shares of Common Stock), registered in the Company’s share register in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of
Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise,
provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company
by such date, and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the
Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the
Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii)
the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company
fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date,
provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company
on or prior to the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a
penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the shares of Common Stock on the date of
the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such
liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are
delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period”
means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with
respect to the shares of Common Stock as in effect on the date of delivery of the Notice of Exercise.

 

ii. Delivery of New Warrants
Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender
of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights
of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be
identical with this Warrant.

 

iii. Rescission
Rights. If the Company fails to cause Computershare Limited, or the then current transfer agent of the Company (the “Transfer
Agent”) to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the
Holder will have the right to rescind such exercise.

 

    4

     

    

 

iv. Compensation for
Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of
Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure solely caused by
incorrect or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of
Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased
exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the
Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant
Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the
number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover
a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder
$1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In
and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the
Warrant as required pursuant to the terms hereof.

 

. No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.

 

. Charges,
Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay
all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or
another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant
Shares.

 

v. Closing
of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

 

    5

     

    

 

e) Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any
other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons,
“Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its
Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable
upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the
Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange
Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the
limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the
Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the
Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of
the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number
of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the
Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public
announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of
shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of
outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the
number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the
shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. The
provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of
this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

Notwithstanding anything
to the contrary contained herein, the Company shall not effect any exercise of this Warrant, and the Holder shall not be entitled to
exercise this Warrant for a number of Warrant Shares in excess of that number of Warrant Shares which, upon giving effect to such exercise,
would cause (i) the aggregate number of shares of Common Stock beneficially owned by the Holder and its Affiliates and any other Persons
whose beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange
Act and the rules and regulations promulgated thereunder, including any “group” of which the Holder is a member, to exceed
19.99% of the total number of issued and outstanding shares of Common Stock of the Company following such exercise, or (ii) the combined
voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial
ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act to exceed 19.99%
of the combined voting power of all of the securities of the Company then outstanding following such exercise, in each case unless Company
shareholder approval is obtained to exceed more than such 19.99% of the total number of issued and outstanding shares of Common Stock
of the Company following such exercise in accordance with the rules of The Nasdaq Stock Market.

 

    6

     

    

 

For purposes of this Section 2(e), the aggregate
number of shares of Common Stock or voting securities beneficially owned by the Holder and its Affiliates and any other Persons whose
beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act shall
include the shares of Common Stock issuable upon the exercise of this Warrant with respect to which such determination is being made,
but shall exclude the number of shares of Common Stock which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled
portion of this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any
other securities of the Company that do not have voting power (including without limitation any securities of the Company which would
entitle the holder thereof to acquire at any time Common Stock, including without limitation any debt, preferred stock, right, option,
warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and
is beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of Common Stock would be aggregated
with the Holder’s for purposes of Section 13(d) of the Exchange Act.

 

Section 3. Certain Adjustments.

 

a) Stock
Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on its shares of Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares of Common Stock, or (iv) issues by reclassification of
shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.

 

b) [RESERVED.]

 

c) Subsequent
Rights Offerings. In addition to (but without duplication of) any adjustments pursuant to Section 3(a) above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).

 

d) Pro Rata
Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other than
cash) or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of stock or other securities, property or options by way of a
dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a
“Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be
entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on
exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is
taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Common Stock are to be
determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right
to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common
Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).

 

    7

     

    

 

e) Fundamental Transaction. If, at
any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any
merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale,
lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series
of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or
another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for
other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding shares of Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one
or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of
Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making
or party to, such stock or share purchase agreement or other business combination) and in connection with such transaction the
Common Stock is converted into or exchanged for other securities, cash or property (each a “Fundamental
Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each
Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction,
at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the securities, cash
and other property of the successor or acquiring corporation (or ultimate parent company thereof) or of the Company, if it is the
surviving corporation, as applicable (the “Alternate Consideration”) receivable as a result of such Fundamental
Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such
Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such
exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on
the amount of Alternate Consideration issuable in respect of one Common Stock in such Fundamental Transaction, and the Company shall
apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of shares of Common Stock are given any choice as to the securities, cash or
property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the
contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity shall, at the Holder’s option,
exercisable at any time concurrently with, or within thirty (30) days after, the consummation of such Fundamental Transaction (or,
if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by
paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of
this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that, if the
Fundamental Transaction is not within the Company’s control, including not approved by the Company’s Board of Directors,
Holder shall only be entitled to receive from the Company or any Successor Entity, the same type or form of consideration (and in
the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the
holders of shares of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in
the form of cash, stock or any combination thereof, or whether the holders of shares of Common Stock are given the choice to receive
from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of
shares of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of
shares of Common Stock will be deemed to have received shares of common stock of the Successor Entity (which Successor Entity may be
the Company following such Fundamental Transaction) in such Fundamental Transaction. “Black Scholes Value” means
the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg,
L.P. (“Bloomberg”) determined as of the day of consummation of the applicable Fundamental Transaction for pricing
purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between
the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected
volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction,
(C) the underlying price per share used in such calculation shall be the sum of the price per share being offered in cash, if any,
plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction, (D) a remaining option time
equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately
available funds within five Business Days of the Holder’s election (or, if later, on the effective date of the Fundamental
Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the
Other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and
substance reasonably satisfactory to the Holder prior to such Fundamental Transaction and shall, at the option of the Holder,
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for the Alternate Consideration, and with an
exercise price which applies the exercise price hereunder to such Alternate Consideration (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such Alternate Consideration, such
number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the Transaction Documents
referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the
Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same
effect as if such Successor Entity had been named as the Company herein.

    8

     

    

 

f) Calculations.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g) Notice
to Holder.

 

i. Adjustment
to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii. Notice
to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
shares of Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the shares of
Common Stock, (C) the Company shall authorize the granting to all holders of the shares of Common Stock rights or warrants to
subscribe for or purchase any capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the shares of Common Stock, any consolidation or merger to which the Company
is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the shares of Common Stock are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to
be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant
Register of the Company, at least five (5) calendar days prior to the applicable record or effective date hereinafter specified, a
notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or
warrants, or if a record is not to be taken, the date as of which the holders of the shares of Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or stock exchange is expected to become effective or close, and the date as of which it is
expected that holders of the shares of Common Stock of record shall be entitled to exchange their shares of Common Stock for
securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or stock exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of
the corporate action required to be specified in such notice and provided further, that no notice shall be required if the
information is disseminated in a press release or document publicly filed with the Commission. To the extent that any notice
provided in this Warrant constitutes, or contains, material, non-public information regarding the Company, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to
exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such
notice except as may otherwise be expressly set forth herein.

 

    9

     

    

 

iii. Voluntary
Adjustments by the Company. The Company may, subject to the rules and regulations of the Trading Market, at any time during the term
of this Warrant, reduce the then current Exercise Price to any amount and extend the term of this Warrant for any period of time deemed
appropriate by the Board of Directors of the Company, with the prior written consent of the Holder.

 

Section 4. Transfer of Warrant.

 

a) Transferability.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Article IV of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are
transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together
with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney
and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment,
the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this
Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall
not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case,
the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment
form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.

 

b) New
Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the
Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial
Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

    10

     

    

 

c) Warrant
Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.

 

d) Transfer
Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.

 

e) Representation
by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.

 

Section 5. Miscellaneous.

 

a) No
Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.

 

b) Loss,
Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c) Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

d) Authorized
Shares.

 

The Company
covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under
this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The
Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein
without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the shares of Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights
represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and
charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring
contemporaneously with such issue).

 

    11

     

    

 

Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.

 

Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.

 

e) Jurisdiction
and Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with Section 5.9 of the Purchase Agreement.

 

f) Restrictions.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g) Nonwaiver
and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h) Notices.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provision in Section 5.4 of the Purchase Agreement.

 

i) Limitation
of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.

 

j) Remedies.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.

 

    12

     

    

 

k) Successors and Assigns. Subject to applicable
securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors
and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended
to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l) Amendment.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder, on the other hand.

 

m) Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n) Headings.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

    13

     

    

 

IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	 	CREATIVE REALITIES, INC. 
	 	 
	 	By:	/s/ Will Logan
	 	Name:	Will Logan
	 	Title:	Chief Financial Officer

 

    14

     

    

 

NOTICE OF EXERCISE

 

TO: CREATIVE REALITIES, INC.

 

(1) The undersigned hereby
elects to purchase________Warrant Shares of the Company pursuant
 to the terms of the attached Warrant (only if exercised in
full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

 (2) Payment shall take the form of (check applicable box):

 

[1 in lawful money of the United States; or

 

[1
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).

 

(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

	 	 	 

 

The Warrant Shares shall be delivered to the following DWAC Account
Number:

 

	 	 	 
	 	 	 
	 	 	 

 

(4) Accredited Investor. The undersigned is an “accredited
investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

_____________________

_____________________

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ________________________________________________________________________

Signature of Authorized Signatory of Investing
Entity: 

Name of Authorized Signatory: ___________________________________________________________________

Title of Authorized Signatory: ____________________________________________________________________

Date: 

 

    15

     

    

 

Exhibit B

 

ASSIGNMENT FORM

 

(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to 

 

	Name:	 	 
	 	 	(Please Print)
	Address:	 	 
	 	 	(Please Print)
	 	 	 
	Phone Number:	 	 
	 	 	 
	Email Address:	 	 
	 	 	 
	Dated: _______________ __, ______	 	 
	 	 	 
	Holder’s Signature:______________________	 	 
	 	 	 
	Holder’s Address:______________________	 	 

 

 

16Exhibit 10.1

 

SECOND AMENDED AND RESTATED LOAN AND SECURITY
AGREEMENT

 

THIS
Second Amended and Restated Loan And Security Agreement (this “Agreement”), dated as of February 17, 2022 (the
“Execution Date”), is by and among (i) Creative Realities, Inc., a Minnesota corporation (“CRI”),
Creative Realities Canada, Inc., an Ontario corporation (“CRCI”), Allure Global Solutions, Inc., a Georgia corporation
(“AGSI” and together with CRI and CRCI, the “Existing Borrowers”) and Reflect Systems, Inc., a Delaware
corporation (“Reflect” or “New Borrower” and together with the Existing Borrowers, each a “Borrower”
and collectively, referred to herein as the “Borrowers”); and Slipstream Communications, LLC, an Anguillan limited
liability company (“Lender”).

 

RECITALS

 

A.  Borrowers
(other than Reflect) and Lender previously entered into that certain Amended and Restated Loan and Security Agreement dated March 7, 2021
(the “Existing Credit Agreement”) pursuant to which Lender made to the Existing Borrowers and to Creative Realities,
LLC, a Delaware limited liability company (“CRLLC”) and Conexus World Global, LLC, a Kentucky limited liability company
(“Conexus” and together with CRLLC being the “Liquidating Borrowers”): (i) a revolving loan in the
original principal amount of up to $1,000,000.00 (the “Existing Revolving Loan”); (ii) a term loan in the original
principal amount of $4,557,433.58 (the “Existing Consolidation Term Loan”); and (iii) a convertible term loan in the
original principal amount of $2,286,213.41 (the “Existing Special Convertible Loan” and together with each of the loans
set forth in (i) and (ii) above, collectively, the “Existing Loans”). Each of the Existing Loans is evidenced by a
promissory note with a maximum principal amount equal to the amount of the Existing Loan set forth in this Recital A (collectively, the
“Existing Notes”).

 

B.  As
of the date hereof, the outstanding principal amount together with accrued and unpaid interest of the Existing Loans evidenced by the
Existing Notes are as follows: (i) the Existing Revolving Loan, $0.00 principal plus accrued but unpaid interest of $0.00; (ii) the Existing
Consolidation Term Loan, $4,767,031.47 principal plus accrued but unpaid interest of $0.00; (iii) the Existing Special Convertible Note,
$2,418,287.59 principal plus accrued but unpaid interest of $0.00 (the principal amounts outstanding plus the accrued but unpaid
interest thereon as of the Closing Date, collectively referred to herein as, the “Existing Advances”).

 

C.  Existing
Borrowers have requested that Lender (i) restructure the Existing Advances, and (ii) make a new loan to Borrowers in an original principal
amount of $10,000,000.00 for the purpose of consummating the acquisition of New Borrower by CRI.

 

D.  Lender
has agreed to the amendment and restatement of the Existing Credit Agreement and replacement of the Existing Notes by the terms of this
Agreement so long as (i) the security interests, Liens and pledges granted to the Lender in the Existing Credit Agreement are preserved
and reaffirmed, (ii) the execution and delivery of this Agreement and the documents and instruments executed in connection herewith not
(a) effect a discharge or novation of any indebtedness or other obligation of the Existing Borrowers under the Existing Credit Agreement
or any of the Existing Notes, but rather a restatement and substitution of certain of the terms governing the payment and performance
of such indebtedness and other obligations, or (b) release Existing Borrowers of any of their Obligations under any Loan Documents or
adversely affect any of the Lender’s rights under any of the Loan Documents, (iii) all security agreements, Liens, security interests,
pledges and guarantees granted in accordance with the Existing Credit Agreement remain in full force and effect in favor of the Lender,
and (iv) Reflect becomes a Borrower under this Agreement and executes such other Loan Documents as may be required by the Lender, pursuant
to which Review will also pledge and grant a Lien on all of its assets to secure its obligations under this Agreement.

 

    1

     

    

 

E.  Capitalized
terms used and not otherwise defined herein shall have the meanings assigned to them in Schedule A.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the foregoing
premises and the mutual covenants herein contained, the parties hereby agree as follows:

 

1.  AMOUNT AND TERMS OF
CREDIT

 

1.1  Existing
Advances. Borrowers acknowledge and agree that (a) as of the Execution Date, the outstanding principal balance of the Existing Advances
including accrued and unpaid interest under the Existing Notes are as set forth in Recital B, above; (b) on the Closing Date, (i) the
Existing Revolving Loan shall be terminated and no longer available to the Borrowers; (ii) the Credit Agreement and the Existing Notes
shall be amended, restated, replaced and superseded in their entirety by this Agreement and the Notes (as defined below), (ii) the Existing
Advances outstanding under the Existing Consolidation Term Loan and the Existing Special Convertible Term Loan together with the accrued
but unpaid interest thereon from February 1, 2022 to the Closing Date shall be deemed to be advances under the Consolidation Term Loan
made pursuant to Section 1.2, below.

 

1.2  Consolidation
Term Loan. Subject to the terms and conditions of this Agreement, Lender is hereby deemed to make an Advance on the Closing Date under
a term loan (the “Consolidation Term Loan”) in the principal amount equal to the sum of the Existing Advances outstanding
on the Closing Date under the Existing Consolidation Term Loan and the Existing Special Convertible Term Loan (which as of the Closing
Date are deemed made under the Consolidation Term Loan to Borrowers). For purposes of clarity, it is understood that in making the Consolidation
Term Loan the Lender is not providing any additional funds to Borrowers. Amounts repaid under the Consolidation Term Loan may not be reborrowed.
The Consolidation Term Loan shall be evidenced by a promissory note in form and substance acceptable to the Lender (the “Consolidation
Term Note,” which shall be delivered in restatement of and replacement for (but not in repayment or satisfaction of) the Existing
Consolidation Term Note and the Existing Special Convertible Term Note.

 

1.3  2022
Acquisition Term Loan. Subject to the terms and conditions of this Agreement, Lender hereby agrees to make a single Advance on the
Closing Date to the Borrowers under a term loan (the “2022 Acquisition Term Loan”) in the principal amount equal to
Ten Million and No/100 Dollars ($10,000,000.00). Amounts repaid under the 2022 Acquisition Term Loan may not be reborrowed. The 2022 Acquisition
Term Loan shall be evidenced by a promissory note in form and substance acceptable to the Lender (the “2022 Acquisition Term
Note”). Subject to the terms and conditions of this Agreement on the Closing Date Lender shall make the 2022 Acquisition Term
Loan pursuant to that certain Instruction Letter dated as of the date hereof by CRI and acknowledged and agreed by Lender.

 

1.4  Evidence
of Indebtedness; Single Loan. Each of the loans set forth in Sections 1.1 through 1.3, above (collectively referred to herein as,
the “Loans”) shall be evidenced by this Agreement. Upon the request of Lender, Borrowers will execute and deliver promissory
notes evidencing any or all of the Loans then outstanding. The Loans and all other Obligations of the Borrowers to Lender arising in connection
with this Agreement and the other Loan Documents shall constitute one general obligation of the Borrowers, secured by all of the Collateral.

 

    2

     

    

 

1.7  Use
of Proceeds. Borrowers shall use the proceeds of the 2022 Acquisition Term Loan solely for the acquisition of Reflect and the proceeds
of the Consolidation Term Loan solely for the general business requirements of the Borrowers.

 

1.8  Interest.
Borrowers shall pay interest to Lender on the outstanding balance of the Loans at the applicable Loan Rate. All computations of interest
shall be made by Lender on the basis of a 360-day year, in each case for the actual number of days occurring in the period for which such
interest or fee is payable. In no event will Lender charge interest at a rate exceeding the highest rate of interest permissible under
any law that a court of competent jurisdiction shall, in a final determination, deem applicable; provided, however, that
if the interest rate exceeds the highest rate of interest permissible under any law applicable to one or more Borrowers, as so determined,
that shall not affect the interest rate chargeable to any other Borrower to which such law is not applicable. Effective upon the occurrence
of an Event of Default and so long as the same shall be continuing, the Loan Rate shall automatically be increased by six percentage points
per annum (6.0%) (such increased rate, the “Default Rate”). Notwithstanding anything to the contrary, that portion
of any interest which is the Default Rate shall be paid in cash. In the event that the Loan Rate or the Default Rate exceeds the highest
rate of interest permissible under any law that a court of competent jurisdiction shall, in a final determination, deem applicable to
one or more Borrower, then the Loan Rate and/or the Default Rate shall be the maximum amount as allowed by applicable law; provided,
however, that if the interest rate exceeds the highest rate of interest permissible under any law applicable to one or more Borrowers,
as so determined, that shall not affect the interest rate chargeable to any other Borrower to which such law is not applicable. Interest
shall accrue on the principal balance of the Loans and shall be paid on a monthly basis and all then-accrued but unpaid interest shall
be paid on the Maturity Date. All accrued and unpaid interest existing after the Termination Date, shall be paid upon demand made by Lender.

 

1.9  Warrants.
On the Closing Date, CRI will execute and deliver to the Lender, the Warrant in substantially the form attached hereto as Exhibit
A.

 

1.10  Payments.
Borrowers hereby jointly and severally promise to pay the amounts outstanding under the Loans as follows:

 

(a)  Cash
Interest Only. Commencing on March 1, 2022 and on the first day of each month, up to and including February 1, 2025, Borrowers
shall make a payment of any accrued and unpaid interest on the Loans to Lender in cash.

 

(c)  Principal
and Interest. Commencing on September 1, 2023, and on the first day of each month thereafter until the Maturity Date, Borrowers
shall make a payment on the Consolidation Term Loan, in an equal monthly installment of principal sufficient to fully amortize the Consolidation
Term Loan in eighteen equal installments.

 

(d)  Payment
in full at Maturity. On the Maturity Date, Borrowers shall pay all outstanding principal remaining on the Loans together with
any accrued and unpaid interest related thereto.

 

If any interest or any other payment to Lender
under this Agreement becomes due and payable on a day other than a Business Day, such payment date shall be extended to the next succeeding
Business Day.

 

1.11  Prepayment
Premium. Borrowers may prepay all or a portion of any Loan at any time without premium or penalty.

 

    3

     

    

 

1.12  Receipt
of Payments. Borrowers shall make each payment under this Agreement without set-off, counterclaim or deduction, and free and clear
of all Taxes, not later than 5:00 p.m., New York City time on the day when due in lawful money of the United States of America in immediately
available funds to such account as Lender shall designate in writing to CRI from time to time (the “Payment Account”).
For purposes of computing interest and fees, all payments shall be deemed received by Lender on the day of receipt of immediately available
funds. All payments of principal, interest, fees and other Obligations shall be paid in cash in U.S. Dollars.

 

1.13   Failure
to Pay in Full. In the event that at any time any payments are due under this Agreement and less than the full amount is paid by Borrowers,
such payments shall first be applied in unpaid fees, then to accrued but unpaid interest on each Loan in such amounts as Lender in its
sole and complete discretion shall determine and then to all principal then due in such amount for each Loan as Lender in its sole and
complete discretion shall determine.

 

1.14  Joinder.
By executing and delivering this Agreement, Reflect hereby becomes a party hereto for all purposes (including, without limitation,
the security interest provisions set forth in this Agreement) and a Borrower hereunder.

 

2.  CONDITIONS

 

2.1  Conditions
Precedent. Lender shall not be obligated to make any Advance or deemed to make any Advance, or to perform any other action hereunder
and the Existing Credit Agreement shall remain in effect, until, all of the following conditions have been satisfied in form and substance
satisfactory to Lender and its counsel and Lender and its counsel have received evidence thereof satisfactory to them:

 

		(a)	the Loan Documents have been executed and delivered by the
Borrowers on or before the Closing Date, including for purposes of clarity the filing of the UCC-1 evidencing the security interest granted
by Reflect in this Agreement, and Lender and its counsel shall have received evidence of the filing thereof;

 

		(b)	Lender has received executed Notes, with the principal amounts
filled in pursuant to this Agreement;

 

		(c)	Officers’ Certificates by officers of each Borrower;

 

		(d)	Lender has received UCC (or in the case of CRCI, the PPSA),
judgment, and tax lien search results with respect to each Borrower from each Borrower’s jurisdiction of formation;

 

		(e)	all Indebtedness of Reflect has been repaid and all security
interests with respect thereto have been released, including Reflect’s lender’s filings with the U. S. Patent and Trademark
Office;

 

		(f)	the Merger (as defined in the Merger Agreement) has become
effective pursuant to the terms of the Merger Agreement on or before the Closing Date; and

 

		(g)	the “Purchaser” under the Equity Purchase Agreement
has issued a waiver to CRI sufficient to permit CRI to issue the Warrant under this Agreement to Lender, notwithstanding the prohibition
set forth in Section 4.12 of the Equity Purchase Agreement.

 

    4

     

    

 

2.2  Additional
Conditions. The obligations of the Lender hereunder in connection with the Closing are subject to the following conditions being
met:

 

		(a)	the accuracy in all material respects when made and on the
Closing Date of the representations and warranties of the Borrowers contained herein (unless as of a specific date herein);

 

		(b)	all obligations, covenants and agreements of the Borrowers
required to be

performed at or prior to the Closing Date shall have been performed;

 

		(c)	the delivery by the Borrowers of the items set forth in Section
2.1 of this Agreement;

 

		(d)	there shall have been no Material Adverse Effect with respect
to the Borrowers since the date hereof; and

 

		(e)	no Default or Event of Default under the Existing Credit Agreement
shall have occurred and be continuing and no Default or Event of Default shall occur under this Agreement upon the Closing Date.

 

3.  REPRESENTATIONS, WARRANTIES
AND COVENANTS

 

To induce Lender to enter
into this Agreement and to make the Loans, each Borrower hereby jointly and severally represents and warrants to Lender (each of which
representations and warranties shall survive the execution and delivery of this Agreement), and promises to and agrees with Lender until
the Termination Date as follows:

 

 3.1 Corporate Existence;
Compliance with Law. Each Borrower: (a) is, as of the Closing Date, and will continue to be at all times (i) a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, (ii) duly qualified to
do business and in good standing (or comparable status in the case of CRCI) in each other jurisdiction where its ownership or lease of
property or the conduct of its business requires such qualification, except where the failure to be so qualified could not reasonably
be expected to have a Material Adverse Effect, and (iii) in compliance with all Requirements of Law, except to the extent failure to comply
therewith could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (b) has and will
continue to have (i) the requisite corporate power and authority and the legal right to execute, deliver and perform its obligations under
the Loan Documents, and to own, pledge, mortgage or otherwise encumber and operate its properties, to lease the property it operates under
lease, and to conduct its business as now, heretofore or proposed to be conducted, and (ii) all licenses, permits, franchises, rights,
powers, consents or approvals from or by all Persons or Governmental Authorities having jurisdiction over such Borrower that are necessary
or appropriate for the conduct of its business.

 

3.2  Executive
Offices; Corporate or Other Names. (a) Each Borrower’s name as it appears in official filings in the state or province of its
incorporation or organization, (b) the type of entity of each Borrower, (c) the organizational identification number issued by each Borrower’s
state or province of incorporation or organization or a statement that no such number has been issued, (d) each Borrower’s state
or province of organization or incorporation, and (e) the location of each Borrower’s chief executive office, corporate offices,
other locations of Collateral and locations where records with respect to Collateral are kept, are as set forth in Disclosure Schedule
3.2 and, except as set forth in such schedule, such locations have not changed during the preceding 12 months.

 

    5

     

    

 

3.3  Corporate
Power; Authorization; Enforceable Obligations. The execution, delivery and performance by each Borrower of the Loan Documents to which
it is a party, and the creation of all Liens provided for herein and therein: (a) are and will continue to be within the Borrower’s
power and authority; (b) have been and will continue to be duly authorized by all necessary or proper action; (c) are not and will not
be in violation of any Requirement of Law or, conflict with, or breach or constitute a default (or an event that with notice or lapse
of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of any Borrower,
or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument (evidencing debt or otherwise) or other understanding to which any Borrower is
a party or by which any property or asset of any Borrower is bound or affected or any other Contractual Obligation of any Borrower, including
the Merger Agreement and the Equity Purchas Agreement; (d) do not and will not result in the creation or imposition of any Lien (other
than Permitted Encumbrances) upon any of the Collateral; and (e) do not and will not require the consent or approval of any Governmental
Authority or any other Person. As of the Closing Date, each Loan Document shall have been duly executed and delivered on behalf of Borrowers,
and each such Loan Document upon such execution and delivery shall be and will continue to be a legal, valid and binding obligation of
all Borrowers, enforceable against them in accordance with its terms, except as such enforcement may be limited by bankruptcy, insolvency
and other similar laws affecting creditors’ rights generally.

 

 3.4 Financial Statements;
Books and Records. All Financial Statements are true, correct and complete and reflect fairly and accurately the financial condition
of the Existing Borrowers (on a consolidated basis) and Reflect as of the date thereof in accordance with GAAP, except (solely with respect
to any interim Financial Statements) the absence of footnotes and normal year-end adjustments. Borrowers shall keep adequate Books and
Records with respect to the Collateral and their business activities in which proper entries, reflecting all consolidated and consolidating
financial transactions, and payments and credits received on, and all other dealings with, the Collateral, will be made in accordance
with GAAP and all Requirements of Law and on a basis consistent with the Financial Statements.

 

 3.5 Material Adverse
Change. Since the date of Borrowers’ most recently audited Financial Statements, no events have occurred that alone or in the
aggregate has had or could reasonably be expected to have a Material Adverse Effect. Borrowers are not in default, and to Borrowers’
knowledge no third party is in default, under or with respect to any of its Contractual Obligations, that alone or in the aggregate has
had or could reasonably be expected to have a Material Adverse Effect.

 

3.6  No
Default or Event of Default. As of the Execution Date and as of the Closing Date no Default or Event of Default shall have occurred
and be continuing.

 

 3.7 Real Estate;
Property. The real estate listed in Disclosure Schedule 3.7 constitutes all of the real property owned, leased, or used
by Borrowers in their business, and Borrowers will not execute any material agreement or contract in respect of such real estate after
the date of this Agreement without giving Lender written notice thereof. Borrowers hold and will continue to hold good and marketable
fee simple title to all of its owned real estate, and good and marketable title to all of its other properties and assets, and valid and
insurable leasehold interests in all of its leases (both as lessor and lessee, sublessee or assignee), and none of the properties and
assets of Borrowers are or will be subject to any Liens, except Permitted Encumbrances.

 

 3.8 Outstanding
Indebtedness; PPP Loans. All outstanding Indebtedness of Borrowers as of the Closing Date, including a statement as to whether such
Indebtedness is secured or unsecured and, if secured, what constitutes the collateral security therefor, is disclosed on Disclosure
Schedule 3.8. All Paycheck Protection Program loans of the Borrowers have been forgiven and all proceeds of such loans were used
only in accordance with the laws, rules and regulations applicable to said Program.

 

 3.9 Government Regulation.
Borrowers are not subject to or regulated under any domestic or foreign federal, national, provincial or state statute, rule or regulation
that restricts or limits such Person’s ability to incur Indebtedness, pledge its assets, or to perform its obligations under the
Loan Documents. The making of the Loans, the application of the proceeds and repayment thereof, and the consummation of the transactions
contemplated by the Loan Documents do not and will not violate any Requirement of Law.

 

    6

     

    

 

3.10  Taxes.
Except as disclosed in Disclosure Schedule 3.10, all Tax returns, reports and statements required by any Governmental Authority
to be filed by Borrowers have, as of the Closing Date, been filed and will, until the Termination Date, be filed with the appropriate
Governmental Authority and no Tax Lien has been filed against Borrowers or their property. Proper and accurate amounts have been and will
be withheld by Borrowers from their employees for all periods in compliance with all Requirements of Law and such withholdings have and
will be timely paid to the appropriate Governmental Authorities. Except as described on Disclosure Schedule 3.10, (i) no
Borrower is liable for any Taxes of any other Person pursuant to any agreement, and (ii) to Borrowers’ knowledge, no Borrower is
liable for any Taxes as a transferee.

 

3.11  Litigation.
No Litigation is pending or, to Borrowers’ knowledge, threatened by or against any Borrower or against Borrowers’ properties
or revenues, nor to Borrowers’ knowledge is there any basis for any Litigation (a) with respect to any of the Loan Documents or
any of the transactions contemplated hereby or thereby, or (b) that could reasonably be expected to have a Material Adverse Effect. Except
as set forth in Disclosure Schedule 3.11, as of the Closing Date there is no Litigation pending or threatened against any
Borrower that seeks damages in excess of $10,000 or injunctive relief, or that alleges criminal misconduct of any Borrower. Borrowers
shall notify Lender promptly in writing upon learning of the existence, threat or commencement of any Litigation against Borrowers or
any allegation of criminal misconduct against any Borrower.

 

3.12   Intellectual
Property. As of the Closing Date, Borrowers own, or are licensed to use, all Intellectual Property necessary to conduct their business
as currently conducted except for such Intellectual Property the failure of which to own or license could not reasonably be expected to
have a Material Adverse Effect. Borrowers will maintain the patenting and registration of all Intellectual Property with the United States
Patent and Trademark Office, the United States Copyright Office, or other appropriate Governmental Authority and Borrowers will promptly
patent or register, as the case may be, all material new Intellectual Property.

 

3.13  Conduct
of Business. Each Borrower (a) shall conduct its business substantially as now conducted or as otherwise permitted hereunder, and
(b) shall at all times maintain, preserve and protect all of the Collateral and Borrower’s other property, used or useful in the
conduct of its business and keep the same in good repair, working order and condition (ordinary wear and tear excepted) and make, or cause
to be made, all necessary or appropriate repairs, replacements and improvements thereto consistent with industry practices.

 

3.14  SEC
Filings. CRI has filed all reports, schedules, forms, statements and other documents required to be filed by CRI under the Securities
Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
“SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. CRI has never been an issuer subject
to Rule 144(i) under the Securities Act.

 

3.15  Solvency.
Each of the Borrowers is solvent.

 

    7

     

    

 

3.16  Merger
Agreement. The representations and warranties of CRI, Reflect and the other parties to the Merger Agreement set forth in the Merger
Agreement were true and correct in all material respects (or, to the extent representations or warranties are qualified by materiality
or Material Adverse Effect, in all respects) when made and are true and correct on the Closing Date. The Merger Agreement has not been
modified or amended. No party to the Merger Agreement has breached any covenants or failed to perform any of its obligations under the
Merger Agreement or has waived any conditions to the consummation of the transactions contemplated thereby.

 

3.17  Equity
Purchase Agreement. The representations and warranties of CRI set forth in the Equity Purchase Agreement were true and correct in
all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all
respects) when made and are true and correct on the Closing Date. Except as set forth on Disclosure Schedule 3.17, the Equity Purchase
Agreement has not been modified or amended. CRI has not breached any covenants or failed to perform any of its obligations under the Equity
Purchase Agreement or has waived any conditions to the consummation of the transactions contemplated thereby.

 

3.18  Liquidating
Borrowers. The Liquidating Borrowers have been dissolved, their businesses wound up and their assets distributed to one or more Borrowers,
all in accordance with the applicable laws of their respective state of organization.

 

3.19  Full
Disclosure. No information contained in any Loan Document, the Financial Statements or any written statement furnished by or on behalf
of any Borrower under any Loan Document, or to induce Lender to execute the Loan Documents, contains any untrue statement of a material
fact or omits to state a material fact necessary to make the statements contained herein or therein not misleading in light of the circumstances
under which they were made.

 

3.20  Reservation
of Securities. CRI shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Warrants
in such amounts as may then be required to issue all of the shares underlying the Warrants.

 

3.21  Further
Assurances. At any time and from time to time, upon the written request of Lender and at the sole expense of Borrowers, Borrowers
shall promptly and duly execute and deliver any and all such further instruments and documents and take such further action as Lender
may reasonably deem desirable (a) to obtain the full benefits of this Agreement and the other Loan Documents, (b) to protect, preserve
and maintain Lender’s rights in any Collateral, or (c) to enable Lender to exercise all or any of the rights and powers herein granted.

 

4.  REPORTS AND NOTICES

 

4.1  Reports
and Information. From the Closing Date until the Termination Date, Borrowers shall deliver to Lender such reports and information
as Lender may reasonably request.

 

4.2  Notices.
Borrowers shall advise Lender promptly, in reasonable detail, of: (a) any Lien, other than Permitted Encumbrances, attaching to or asserted
against any of the Collateral; or (b) the occurrence of any Default or other event that has had or could reasonably be expected to have
a Material Adverse Effect.

 

5.  NEGATIVE COVENANTS

 

Borrowers covenant
and agree that, without Lender’s prior written consent, from the Closing Date until the Termination Date, Borrowers shall not, directly
or indirectly, by operation of law or otherwise:

 

(a)  form
any subsidiary or merge with or into, consolidate with, acquire all or substantially all of the assets or capital stock of, or otherwise
combine with or make any investment in or make any loan or advance to, any Person;

 

    8

     

    

 

(b)  cancel
any debt owing to it or create, incur, assume or permit to exist any Indebtedness, except: (i) the Obligations, (ii) Indebtedness existing
as of the Closing Date (including increases, extensions, renewals and replacements thereof; provided, however that this parenthetical
shall not apply to the Reflect Note) and listed on Disclosure Schedule 3.8,or amend or waive any provision of the Reflect
Note or prepay any portion of the Reflect Note, (iii) deferred Taxes, (iv) by endorsement of Instruments or items of payment for deposit
to the general account of Borrower, (v) Purchase Money Indebtedness, (v) unsecured Indebtedness incurred after the Closing Date that is
junior to the Obligations in an aggregate amount outstanding at any time not to exceed $500,000;

 

(c)  make
any changes in any of its business objectives, purposes, or operations that could reasonably be expected to adversely affect repayment
of the Obligations or could reasonably be expected to have a Material Adverse Effect or engage in any business other than that presently
engaged in or proposed to be engaged in on the Closing Date, or amend its Articles of Incorporation (or Articles or Certificate of Organization,
as applicable) or Bylaws or other organizational documents;

 

(d)  create
or permit any Lien on any of its properties or assets, except for Permitted Encumbrances including those set forth on Disclosure
Schedule 5(d);

 

(e)  sell,
transfer, issue, convey, assign or otherwise dispose of any of its material assets or properties;

 

(f)  change
(i) its name as it appears in official filings in the state or province of its incorporation or organization, (ii) its chief executive
office, corporate offices or other Collateral locations, or location of its records concerning the Collateral, (iii) the type of legal
entity that it is, (iv) its organization identification number, if any, issued by its state or province of incorporation or organization,
or (v) its state or province of incorporation or organization, in each instance without giving at least 30 days prior written notice thereof
to Lender and taking all actions, at Borrowers’ expense, deemed necessary or appropriate by Lender to continuously protect and perfect
Lender’s Liens upon the Collateral; or

 

(g)  make
or permit any Restricted Payment.

 

6.  SECURITY
INTEREST

 

6.1  Grant
of Security Interest. As collateral security for the prompt and complete payment and performance of the Obligations, each Borrower
hereby grants and reaffirms its grant pursuant to the Existing Credit Agreement to the Lender a security interest in and Lien upon (and
all such comparable rights under the PPSA with respect to CRCI) all of its property and assets, whether real or personal, tangible or
intangible, and whether now owned or hereafter acquired, or in which it now has or at any time in the future may acquire any right, title,
or interest, including without limitation all of the following property (collectively, the “Collateral”):

 

(i)  all
Accounts, as such capitalized term is defined in the Code;

 

(ii)  all
Deposit Accounts, as such capitalized term is defined in the Code, all other bank accounts and all funds on deposit therein;

 

(iii)  all
money, cash and cash equivalents;

 

    9

     

    

 

(iv)  all
Investment Property, as such capitalized term is defined in the Code;

 

(v)  all
stock; provided however in the case of the stock of CRCI, only 60% of its voting stock);

 

(vi)  all
Goods, including Inventory, Equipment and Fixtures, as such capitalized terms are defined in the Code;

 

(vii)  all
Chattel Paper, Documents and Instruments, as such capitalized terms are defined in the Code;

 

(viii)  all
Books and Records;

 

(ix)  all
General Intangibles, including all Intellectual Property, contract rights, including all of Borrowers’ rights under the Merger Agreement
(including rights to indemnification), choses in action, Payment Intangibles and Software, as such capitalized terms are defined in the
Code;

 

(x)  all
Letter-of-Credit Rights, as such capitalized term is defined in the Code;

 

(xi)  all
Supporting Obligations, as such capitalized term is defined in the Code; and

 

(xii)  to
the extent not otherwise included, all Proceeds (as such capitalized term is defined in the Code), tort claims, insurance claims, indemnification
claims under the Merger Agreement and other rights to payment not otherwise included in the foregoing, and products of all and any of
the foregoing and all accessions to, substitutions and replacements for, and rents and profits of, each of the foregoing.

 

6.2  Other
Agreements and Acknowledgments. Each Borrower and Lender agree that this Agreement creates, and is intended to create, valid and continuing
Liens upon the Collateral in favor of Lender in the manner described herein. Borrowers represent, warrant and promise to Lender that:
(i) each Borrower has rights in and the power to transfer each item of the Collateral upon which it purports to grant a Lien pursuant
to the Loan Documents, free and clear of any and all Liens or claims of others, other than Permitted Encumbrances; (ii) the security interests
granted pursuant to this Agreement will, upon completion of filings and other actions required under applicable law, constitute valid
perfected security interests in all of the Collateral in favor of the Lender as security for the prompt and complete payment and performance
of the Obligations, enforceable in accordance with the terms hereof against any and all creditors of and purchasers from Borrowers (other
than purchasers of Inventory in the ordinary course of business) and such security interests will, upon the satisfaction of the aforementioned
conditions, be prior to all other Liens on the Collateral in existence on the date hereof except for Permitted Encumbrances that have
priority by operation of law; and (iii) no effective security agreement, mortgage, deed of trust, financing statement, equivalent security
or Lien instrument or continuation statement covering all or any part of the Collateral is or will be on file or of record in any public
office, except those relating to Permitted Encumbrances. Borrowers promise to defend the right, title and interest of Lender in and to
the Collateral against the claims and demands of all Persons whomsoever.

 

6.3  Collection
of Outstanding Accounts. Borrowers agree to use commercially reasonable efforts, and consistent with past practices, to collect on
the Accounts.

 

    10

     

    

 

7.  EVENTS OF DEFAULT; RIGHTS
AND REMEDIES

 

7.1  Events
of Default. The occurrence of any one or more of the following events (regardless of the reason therefor) shall constitute an “Event
of Default” hereunder which shall be deemed to be continuing until waived in writing by Lender in accordance with Section 11.3
or until cured by Borrowers:

 

(a)  Borrowers
shall fail to make any payment in respect of any Obligations when due and payable or declared due and payable;

 

(b)  Borrowers
shall fail or neglect to perform, keep or observe any of the covenants, promises, agreements, requirements, conditions or other terms
or provisions contained in this Agreement or any of the other Loan Documents with no cure having been effected (to the extent capable
of being cured) by Borrowers within (i) ten (10) days with respect to Section 2.3, Section 5(b) and Section 5(g) above, and (ii) twenty
(20) days with respect to other provisions not enumerated in this Section 7.1, after the occurrence thereof (such ten-day cure period
not being applicable to the conditions subsequent in Section 2.3, above);

 

(c)  an
event of default shall occur under any Contractual Obligation of the Borrowers (other than this Agreement and the other Loan Documents),
and such event of default (i) involves the failure to make any required payment, whether of principal, interest or otherwise, and whether
due by scheduled maturity, required prepayment, acceleration, demand or otherwise, in respect of any Indebtedness (other than the Obligations)
of such Person in an aggregate amount exceeding the Minimum Actionable Amount, or (ii) causes (or permits any holder of such Indebtedness
or a trustee to cause) such Indebtedness, or a portion thereof, in an aggregate amount exceeding the Minimum Actionable Amount, to become
due prior to its stated maturity or prior to its regularly scheduled date of payment;

 

(d)  any
representation or warranty in this Agreement or any other Loan Document, or in any written statement pursuant hereto or thereto, or in
any report, financial statement or certificate made or delivered to Lender by Borrowers shall be materially untrue or incorrect as of
the date when made or deemed made;

 

(e)  Borrowers
shall fail to pay, as or when due, or fail or neglect to perform or breach any Contractual Obligations under or in connection with the
Merger Agreement or the Equity Purchase Agreement which might reasonably have a Material Adverse Effect; or Reflect Exit Corporation breaches
the Lien Subordination Agreement between it and Lender;

 

(f)  there
shall be commenced against Borrowers any Litigation seeking issuance of a warrant of attachment, execution, distraint or similar process
against all or any substantial part of its assets that results in the entry of an order for any such relief that remains unstayed or undismissed
for 30 consecutive days; or Borrowers shall have concealed, removed or permitted to be concealed or removed, any part of its property
with intent to hinder, delay or defraud any of its creditors or made or suffered a transfer of any of its property or the incurring of
an obligation that may be fraudulent under any bankruptcy, fraudulent transfer or other similar law; or

 

(g)  a
case or proceeding shall have been commenced involuntarily against any Borrower in a court having competent jurisdiction seeking a decree
or order: (i) under the United States Bankruptcy Code or any other applicable federal, national, provincial, state or foreign bankruptcy
or other similar law, and seeking either (A) the appointment of a custodian, receiver, liquidator, assignee, trustee or sequestrator (or
similar official) for such Person or of any substantial part of its properties, or (B) the reorganization or winding up or liquidation
of the affairs of any such Person, and such case or proceeding shall remain undismissed or unstayed for 60 consecutive days or such court
shall enter a decree or order granting the relief sought in such case or proceeding; or (ii) invalidating or denying any Person’s
right, power, or competence to enter into or perform any of its obligations under any Loan Document or invalidating or denying the validity
or enforceability of this Agreement or any other Loan Document or any action taken hereunder or thereunder; or

 

    11

     

    

 

(h)  Any
Borrower shall (i) commence any case, proceeding or other action under any existing or future law of any jurisdiction, domestic or foreign,
relating to bankruptcy, insolvency, reorganization, conservatorship or relief of debtors, seeking to have an order for relief entered
with respect to it or seeking appointment of a custodian, receiver, liquidator, assignee, trustee or sequestrator (or similar official)
for it or any substantial part of its properties, (ii) make a general assignment for the benefit of creditors, (iii) consent to or take
any action in furtherance of, or, indicating its consent to, approval of, or acquiescence in, any of the acts set forth in paragraphs
(e) or (f) of this Section or clauses (i) and (ii) of this paragraph, or (iv) shall admit in writing its inability to, or shall be generally
unable to, pay its debts as such debts become due; or

 

(i)  a
judgment or judgments for the payment of money in excess of the Minimum Actionable Amount in the aggregate shall be rendered against Borrowers,
unless the same shall be fully covered by insurance and the issuer(s) of the applicable policies shall have acknowledged full coverage
in writing within 15 days of judgment, or (ii) vacated, stayed, bonded, paid or discharged within a period of 15 days from the date of
such judgment.

 

7.2  Remedies.
(a) If any Default shall have occurred and be continuing, then Lender may, upon written notice to Borrowers, take any one or more of the
following actions: (i) declare all or any portion of the Obligations to be forthwith due and payable, whereupon such Obligations shall
become and be due and payable; or (ii) exercise any rights and remedies provided to Lender under the Loan Documents or at law or equity,
including all remedies provided under the Code; provided, however, that upon the occurrence of any Event of Default specified in Sections
7.1 (f), (g) or (h), the Obligations shall become immediately due and payable without presentment, protest, declaration, notice or demand
by Lender, all of which are expressly waived by Borrower.

 

(b)  Without
limiting the generality of the foregoing, Borrowers expressly agree that upon the occurrence of any Event of Default, Lender may collect,
receive, assemble, process, appropriate and realize upon the Collateral, or any part thereof, and may forthwith sell, lease, assign, give
an option or options to purchase or otherwise dispose of and deliver said Collateral (or contract to do so), or any part thereof, in one
or more parcels at public or private sale or sales, at any exchange at such prices as it may deem best, for cash or on credit or for future
delivery without assumption of any credit risk. Lender shall have the right upon any such public sale, to the extent permitted by law,
to purchase for the benefit of Lender the whole or any part of said Collateral so sold. Such sales may be adjourned, or continued from
time to time with or without notice. Lender shall have the right to conduct such sales on Borrowers’ premises or elsewhere and shall
have the right to use any Borrower’s premises without rent or other charge for such sales or other action with respect to the Collateral
for such time as Lender deems necessary or advisable.

 

(c)  Upon
the occurrence and during the continuance of an Event of Default and at Lender’s request, Borrowers agree, to assemble the Collateral
and make it available to Lender at places that Lender shall reasonably select, whether at its premises or elsewhere. Until Lender is able
to effect a sale, lease, or other disposition of the Collateral, Lender shall have the right to complete, assemble, use or operate the
Collateral or any part thereof, to the extent that Lender deems appropriate, for the purpose of preserving such Collateral or its value
or for any other purpose. Lender shall have no obligation to Borrowers to maintain or preserve the rights of Borrowers as against third
parties with respect to any Collateral while such Collateral is in the possession of Lender. Lender may, if it so elects, seek the appointment
of a receiver or keeper to take possession of any Collateral and to enforce any of Lender’s remedies with respect thereto without
prior notice or hearing. To the maximum extent permitted by applicable law, Borrowers waive all claims, damages, and demands against Lender,
its Affiliates, agents, and the officers and employees of any of them arising out of the repossession, retention or sale of any Collateral
except such as are determined in a final judgment by a court of competent jurisdiction to have arisen solely out of the gross negligence
or willful misconduct of such Person. Borrowers agree that ten days’ prior notice by Lender to Borrowers of the time and place of
any public sale or of the time after which a private sale may take place is reasonable notification of such matters. Borrowers shall remain
liable for any deficiency if the proceeds of any sale or disposition of the Collateral are insufficient to pay all amounts to which Lender
is entitled.

 

(d)  Lender’s
rights and remedies under this Agreement shall be cumulative and nonexclusive of any other rights and remedies that Lender may have under
any Loan Document or at law or in equity. Recourse to the Collateral shall not be required. All provisions of this Agreement are intended
to be subject to all applicable mandatory provisions of law that may be controlling and to be limited, to the extent necessary, so that
they do not render this Agreement invalid or unenforceable, in whole or in part.

 

7.3  Proceeds.
The Proceeds of any sale, disposition or other realization upon any Collateral shall be applied by Lender upon receipt to the Obligations
in such order as Lender may deem advisable in its sole and complete discretion, and after the indefeasible payment and satisfaction in
full in cash of all of the Obligations, and after the payment by Lender of any other amount required by any provision of law, including
Sections 9-608(a)(l) and 9-615(a)(3) of the Code (but only after Lender has received what Lender considers reasonable proof of a subordinate
party’s security interest), the surplus, if any, shall be paid to Borrowers or their representatives or to whomsoever may be lawfully
entitled to receive the same, or as a court of competent jurisdiction may direct.

 

    12

     

    

 

8.  REGISTRATION
RIGHTS; INDEMNIFICATION.

 

8.1  Registration
Rights.

 

(a)  CRI
previously filed with the Commission a registration statement on Form S-3 registering the resale of certain shares of the common stock
of CRI previously issued under the Existing Loan Agreement (as amended from time to time, the “Registration Statement”).
CRI will agree to make such filings as are necessary to keep the Registration Statement effective until the earliest of (i) such time
as all Shares (as defined in the Existing Credit Agreement as in effect immediately prior to its amendment hereby) held by Lender and
registered under the Registration Statement have been sold; or (ii) the date on which Lender may sell such Shares without restriction
under Rule 144 promulgated under the Securities Act (including, without limitation, volume restrictions). If after the date the Registration
Statement is declared effective, Lender seeks to sell the Shares, CRI shall take all actions reasonably necessary to allow, and shall
use reasonable best efforts to ensure that CRI’s transfer agent and counsel facilitate the sale or transfer of the subject Shares
pursuant to the Registration Statement.

 

(b)  CRI shall:

 

(i)  advise
Lender within two (2) business days:

 

(1) when any post-effective amendment
thereto has become effective;

 

(2) of any request by the Commission for
amendments or supplements to the Registration Statement or the prospectus included therein or for additional information with respect
thereto;

 

(3) of the issuance by the Commission
of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for such purpose;

 

(4) of the receipt by CRI of any notification
with respect to the suspension of the qualification of the Shares included therein for sale in any jurisdiction or the initiation or threatening
of any proceeding for such purpose; and

 

(5) if it learns that any statement included
in the Registration Statement or related prospectus is misleading and omits to state a material fact required to be stated therein or
necessary to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not
misleading.

 

Notwithstanding anything to the contrary
set forth herein, CRI shall not, when so advising Lender of such events, provide Lender with any material, nonpublic information regarding
CRI;

 

(ii) use its commercially reasonable best
efforts to obtain the withdrawal of any order suspending the effectiveness of the Registration Statement as soon as reasonably practicable;

 

(iii) upon the occurrence of any event
contemplated above, except for such times as CRI is permitted hereunder to suspend, and has suspended, the use of a prospectus forming
part of the Registration Statement, CRI shall use its best efforts to as soon as reasonably practicable prepare a post-effective amendment
to such Registration Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered
to Lender, such prospectus will not include any untrue statement of a material fact or omit to state any material fact necessary to make
the statements therein, in the light of the circumstances under which they were made, not misleading;

 

(iv)
furnish to the Lender such number of copies of the prospectus, including all amendments and supplements thereto as well as the preliminary
prospectus, in conformity with the requirements of the Securities Act, and such other documents as it may reasonably request in order
to facilitate the disposition of the Shares;

 

(v) use all commercially reasonable efforts
to register and qualify the securities covered by such registration statement under such other securities or blue sky laws of such jurisdictions
as shall be reasonably requested by the Participating Holders; provided, however, that CRI shall not be required in connection
therewith or as a condition thereto to qualify to do business in, or to file a general consent to service of process in, or to subject
itself to taxation in regard to its ordinary operations by, any such states or jurisdictions;

 

(vi) use its commercially reasonable best
efforts to cause all the Shares to be listed on each securities exchange or market, if any, on which equity securities issued by CRI have
been listed; and

 

(vii) use its commercially reasonable
best efforts to take all other steps necessary to effect the registration of the Shares.

 

(c) Borrower’s obligations under
this Section 8.1 shall survive the termination of this Agreement.

 

    13

     

    

 

8.2  Indemnification.
CRI shall, notwithstanding any termination of this Agreement, indemnify, defend and hold harmless Lender (to the extent a seller under
any Registration Statement), the officers, directors, agents, partners, members, managers, stockholders, affiliates, employees and investment
advisers of each of them, each person who controls Lender (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act) and the officers, directors, partners, members, managers, stockholders, agents, affiliates, employees and investment
advisers of each such controlling person (all the foregoing, the “Indemnified Parties”), to the fullest extent permitted
by applicable law, from and against any and all losses, claims, demands, suits, actions, judgments, damages, liabilities, costs (including,
without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, that arise
out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any prospectus
included in any Registration Statement or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus,
or arising out of or relating to any omission or alleged omission to state a material fact required to be stated therein or necessary
to make the statements therein (in the case of any prospectus or form of prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading, or (ii) any violation or alleged violation by CRI of the Securities Act, Exchange Act or any
state securities law or any rule or regulation thereunder, in connection with the performance of its obligations under this Section, except
to the extent, but only to the extent, that such untrue statements, untrue statements, omissions or omissions are based upon information
regarding Lender furnished in writing by Lender to CRI expressly for use therein. CRI shall notify Lender promptly of the institution,
threat or assertion of any proceeding arising from or in connection with the transactions contemplated by this Section of which CRI is
or becomes aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an indemnified
party and shall survive the transfer of any Shares by Lender. Borrower’s obligations under this Section 8.2 shall survive the termination
of this Agreement.

 

9.  SUCCESSORS
AND ASSIGNS

 

Each Loan Document shall be
binding on and shall inure to the benefit of Borrowers, Lender and their respective successors and assigns, except as otherwise provided
herein or therein. Borrowers may not assign, transfer, hypothecate, delegate or otherwise convey its rights, benefits, obligations or
duties under any Loan Document without the prior express written consent of Lender. Any such purported conveyance by Borrowers without
the prior express written consent of Lender shall be void. There shall be no third-party beneficiaries of any of the terms and provisions
of any of the Loan Documents.

 

10.  RELEASE
(a) Each Borrower hereby acknowledges and agrees that: (i) no Borrower or any Liquidating Borrower has any claim or cause of action
against the Lender (or any of its Affiliates or its or their officers, directors, employees, managers, members, partner, shareholders,
attorneys or consultants) in connection with the Loan Documents (as defined in the Existing Credit Agreement) and (ii) the Lender has
heretofore properly performed and satisfied in a timely manner all of its obligations to Borrowers and the Liquidating Borrowers under
the Existing Credit Agreement and the other Loan Documents (as defined in the Existing Credit Agreement) that are required to have been
performed on or prior to the date hereof. Notwithstanding the foregoing, the Lender wishes (and Borrowers agree) to eliminate any possibility
that any past conditions, acts, omissions, events or circumstances would impair or otherwise adversely affect any of the Lender’s
rights, interests, security and/or remedies under the Existing Credit Agreement and the other Loan Documents (as defined in the Existing
Credit Agreement) or under this Agreement or any other Loan Document. Accordingly, for and in consideration of the agreements contained
in this Agreement and other good and valuable consideration, each Borrower (for itself and each other Borrower and the Liquidating Borrowers
and the successors, assigns, heirs and representatives of each of the foregoing) (collectively, the “Releasors”) does
hereby fully, finally, unconditionally and irrevocably release and forever discharge Lender and each of its Affiliates and its and their
managers, members, partners, officers, directors, employees, shareholders attorneys and consultants in their capacities as or for the
Lender (collectively, the “Released Parties”) from any and all debts, claims, obligations, damages, costs, attorneys’
fees, suits, demands, liabilities, actions, proceedings and causes of action, in each case, whether known or unknown, contingent or fixed,
direct or indirect, and of whatever nature or description, and whether in law or in equity, under contract, tort, statute or otherwise,
which any Releasor has heretofore had or now or hereafter can, shall or may have against any Released Party by reason of any act, omission
or thing whatsoever done or omitted to be done directly arising out of, connected with or related to the Existing Credit Agreement or
any other Loan Document (as defined in the Existing Credit Agreement), or any act, event or transaction related or attendant thereto,
or the agreements of the Lender contained therein, or the possession, use, operation or control of any of the assets of any Borrower,
or the making of any Loans or other Advances, or the management of such Loans or Advances or the Collateral, in each case, solely to the
extent arising from any act, omission or thing whatsoever done or omitted to be done on or prior to the Closing Date.

 

    14

     

    

 

 11. GENERAL PROVISIONS

 

 11.1 Complete Agreement;
Modification of Agreement. This Agreement and the other Loan Documents constitute the complete agreement between the parties with
respect to the subject matter hereof and thereof, supersede all prior agreements, commitments, understandings or inducements (oral or
written, expressed or implied). No Loan Document may be modified, altered or amended except by a written agreement signed by Lender and
Borrowers.

 

 11.2 Expenses.
Borrowers agree to pay their own costs and expenses (including the fees and expenses of all counsel, advisors, consultants and auditors
retained in connection therewith), incurred in connection with the preparation, negotiation, execution and delivery of, and, other than
as specifically set forth herein, the performance of obligations under, the Loan Documents. Borrowers, jointly and severally, agree to
also pay Lender’s costs and expenses (including the fees and expenses of all counsel, advisors, consultants and auditors retained
in connection therewith), incurred in connection with the preparation, negotiation (including the negotiation of the terms of any other
contemplated amendment to the Existing Credit Agreement and related documents), execution and delivery of, and, other than as specifically
set forth herein, the performance of obligations under, the Loan Documents and any future amendment of or waiver under any Loan Document
and the enforcement of the rights and remedies hereunder and thereunder, including reimbursing Lender for any of such costs and expenses
paid by Lender.

 

 11.3 No Waiver.
Neither Lender’s failure, at any time, to require strict performance by Borrowers of any provision of any Loan Document, nor Lender’s
failure to exercise, nor any delay in exercising, any right, power or privilege hereunder, shall operate as a waiver thereof or waive,
affect or diminish any right of Lender thereafter to demand strict compliance and performance therewith. No single or partial exercise
of any right, power or privilege hereunder shall preclude any other or future exercise thereof or the exercise of any other right, power
or privilege. Any suspension or waiver of a Default or other provision under the Loan Documents shall not suspend, waive or affect any
other Default or other provision under any Loan Document, and shall not be construed as a bar to any right or remedy that Lender would
otherwise have had on any future occasion. None of the undertakings, indemnities, agreements, warranties, covenants and representations
of Borrowers to Lender contained in any Loan Document and no Default by Borrowers under any Loan Document shall be deemed to have been
suspended or waived by Lender, unless such waiver or suspension is by an instrument in writing signed by an officer or other authorized
employee of Lender and directed to Borrowers specifying such suspension or waiver (and then such waiver shall be effective only to the
extent therein expressly set forth), and Lender shall not, by any act (other than execution of a formal written waiver), delay, omission
or otherwise, be deemed to have waived any of its rights or remedies hereunder.

 

    15

     

    

 

 11.4 Severability.
Wherever possible, each provision of the Loan Documents shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of any Loan Document shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of such
Loan Document. Except as otherwise expressly provided for in the Loan Documents, no termination or cancellation (regardless of cause or
procedure) of any financing arrangement under the Loan Documents shall in any way affect or impair the Obligations, duties, covenants,
representations and warranties, indemnities, and liabilities of Borrowers or the rights of Lender relating to any unpaid Obligation, (due
or not due, liquidated, contingent or unliquidated), or any transaction or event occurring prior to such termination, or any transaction
or event, the performance of which is not required until after the Termination Date, all of which shall not terminate or expire, but rather
shall survive such termination or cancellation and shall continue in full force and effect until the Termination Date; provided, however,
that all indemnity obligations of Borrowers under the Loan Documents shall survive the Termination Date.

 

 11.5 Notices.
Except as otherwise provided herein, whenever any notice, demand, request or other communication shall or may be given to or served upon
any party by any other party, or whenever any party desires to give or serve upon any other party any communication with respect to this
Agreement, each such communication shall be in writing and shall be deemed to have been validly served, given or delivered (a) three days
after deposit in the United States Mail, registered or certified mail, return receipt requested, with proper postage prepaid, (b) upon
confirmed receipt, when sent by email transmission, (c) one Business Day after deposit with a reputable overnight courier with all charges
prepaid or (d) when hand-delivered, all of which shall be addressed to the party to be notified and sent to the address or facsimile number
indicated on the signature pages hereto or to such other address (or facsimile number) as may be substituted by notice given as herein
provided.

 

 11.6 Counterparts;
Construction. Any Loan Document may be authenticated in any number of separate counterparts by any one or more of the parties thereto,
and all of said counterparts taken together shall constitute one and the same instrument. Valid and binding signatures to any Loan Document
may be delivered in original ink, by facsimile or by email or other means of electronic transmission. All references to “including”
or any similar term shall mean “including without limitation” and all references to “satisfaction” or “may”
of or by Lender or its counsel or any similar term shall mean “in its sole and complete discretion.”

 

 11.7 Governing Law.
The Loan Documents and the obligations arising under the Loan Documents shall be governed by, and construed and enforced in accordance
with, the laws of the State of New York applicable to contracts made and performed in such state, without regard to the principles thereof
regarding conflicts of laws.

 

 11.8 Submission
To Jurisdiction; Waiver Of Jury Trial. (A) BORROWERS HEREBY CONSENT AND AGREE THAT THE STATE OR FEDERAL COURTS LOCATED IN NEW YORK
CITY, NEW YORK, SHALL HAVE EXCLUSIVE JURISDICTION TO HEAR AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN BORROWERS AND LENDER PERTAINING
TO THIS AGREEMENT OR ANY OF THE OTHER LOAN DOCUMENTS OR TO ANY MATTER ARISING OUT OF OR RELATED TO THIS AGREEMENT OR ANY OF THE OTHER
LOAN DOCUMENTS; PROVIDED, HOWEVER, THAT NOTHING IN THIS AGREEMENT SHALL BE DEEMED OR OPERATE TO PRECLUDE LENDER FROM BRINGING
SUIT OR TAKING OTHER LEGAL ACTION IN ANY OTHER JURISDICTION TO COLLECT THE OBLIGATIONS, TO REALIZE ON THE COLLATERAL OR ANY OTHER SECURITY
FOR THE OBLIGATIONS, OR TO ENFORCE A JUDGMENT OR OTHER COURT ORDER IN FAVOR OF LENDER. BORROWERS EXPRESSLY SUBMIT AND CONSENT IN ADVANCE
TO SUCH JURISDICTION IN ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURT, AND BORROWERS HEREBY WAIVE ANY OBJECTION THAT IT MAY HAVE BASED
UPON LACK OF PERSONAL JURISDICTION, IMPROPER VENUE OR FORUM NON CONVENIENS.

 

    16

     

    

 

(B)  THE
PARTIES HERETO WAIVE ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, SUIT, OR PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE, WHETHER ARISING IN
CONTRACT, TORT, OR OTHERWISE BETWEEN LENDER AND BORROWERS ARISING OUT OF, CONNECTED WITH, RELATED OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED
BETWEEN THEM IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS RELATED THERETO.

 

11.9  Reinstatement.
This Agreement shall continue to be effective, or be reinstated, as the case may be, if at any time payment of all or any part of the
Obligations is rescinded or must otherwise be returned or restored by Lender upon the insolvency, bankruptcy, dissolution, liquidation
or reorganization of Borrower, or otherwise, all as though such payments had not been made.

 

11.10  Joint
and Several. Each Borrower agrees that it is jointly and severally liable for, and absolutely and unconditionally guarantees to Lender
the prompt payment and performance of, all Obligations under this Agreement and all agreements under the Loan Documents.

 

11.11  Amendment
And Restatement; No Novation. This Agreement constitutes an amendment and restatement of the Existing Credit Agreement and the Existing
Notes, as amended, effective from and after the date hereof. Neither the execution and delivery of this Agreement nor the consummation
of the transactions contemplated hereby shall constitute a novation of any indebtedness or other obligations owing to Lender under the
Existing Credit Agreement and Existing Notes. As of the Closing Date, the credit facilities described in the Existing Credit Agreement,
as amended, shall be amended, supplemented, modified and restated in their entirety by the facilities described herein, and all loans
and other obligations of the Borrowers outstanding as of such date under the Existing Credit Agreement and Existing Notes, as amended,
shall be deemed to be loans and obligations outstanding under the corresponding facilities described herein, without any further action
by Lender.

 

[SIGNATURE PAGE FOLLOWS]

 

    17

     

    

 

IN WITNESS WHEREOF,
this Second Amended and Restated Loan and Security Agreement has been duly executed as of the date first written above.

 

	BORROWERS:	 	LENDER:
	 	 	 
	Creative Realities, Inc.	 	Slipstream Communications, LLC
	Creative Realities Canada, Inc.	 	 
	Allure Global Solutions, Inc.	 	 
	Reflect Systems, Inc.	 	 
	 	 	 	 
	/s/ Richard Mills	 	/s/ Brian Friedman
	By:	Richard Mills	 	By:	                           
	Title:	Chief Executive Officer	 	Title:	 
	 	 	 	 	 
	Address for Notice (for all Borrowers):	 	Address for Notice:
	Creative Realities, Inc.	 	 	 
	Attention: Chief Financial Officer	 	 	 
	13100 Magisterial Dr, Ste. 100	 	 	 
	Louisville, KY 40223	 	 	 

 

     

     

    

 

SCHEDULE A – DEFINITIONS

 

Capitalized terms used in
this Agreement and the other Loan Documents shall have (unless otherwise provided elsewhere in this Agreement or in the other Loan Documents)
the following respective meanings:

 

“Advance”
means any advance or deemed advance of Loan proceeds under this Agreement, as outlined in Section 1 or otherwise.

 

“Affiliate”
means, with respect to any Person: (a) each other Person that, directly or indirectly, owns or controls, whether beneficially, or as a
trustee, guardian or other fiduciary, 10% or more of the voting capital stock having ordinary voting power for the election of directors
of such Person; (b) each other Person that controls, is controlled by or is under common control with such Person or any Affiliate of
such Person; or (c) each of such Person’s officers, directors, joint venturers and partners. For the purpose of this definition,
“control” of a Person shall mean the possession, directly or indirectly, of the power to direct or cause the direction of
its management or policies, whether through the ownership of voting securities, by contract or otherwise.

 

“Agreement”
means this Agreement, including all appendices, exhibits or schedules attached or otherwise identified thereto, restatements and modifications
and supplements thereto, and any appendices, exhibits or schedules to any of the foregoing, each as effect at the time such reference
becomes operative.

 

“Bankruptcy Event”
means the occurrence of any event referred to in either Section 7.1(g) or (h).

 

“Books and Records”
means all books, records, board minutes, contracts, licenses, insurance policies, environmental audits, business plans, files, computer
files, computer discs and other data and software storage and media devices, accounting books and records, financial statements (actual
and pro forma), filings with Governmental Authorities and any and all records and instruments relating to the Collateral or any Borrower’s
business.

 

“Borrower”
means each of Creative Realities, Inc., Creative Realities Canada, Inc., Allure Global Solutions, Inc., and Reflect Systems, Inc., and
“Borrowers” means all of the foregoing and each of them individually.

 

“Business Day”
means any day that is not a Saturday, a Sunday or a day on which banks are required or permitted to be closed in the State of New York.

 

“Closing Date”
means the time on the Business Day on which the conditions precedent set forth in Section 2.1 and 2.2 have been satisfied or specifically
waived in writing by Lender, and the Consolidation Term Loan is deemed made pursuant hereto and the 2022 Acquisition Term Loan is made
pursuant hereto.

 

“Code”
means the Uniform Commercial Code as the same may, from time to time, be in effect in the State of New York; provided, however, that in
the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection or priority of, or remedies with respect
to, the Lender’s Lien on any Collateral is governed by the Uniform Commercial Code as in effect in a jurisdiction other than the
State of New York, then the term “Code” shall mean the Uniform Commercial Code as in effect in such other jurisdiction for
purposes of the provisions of this Agreement relating to such attachment, perfection, priority or remedies and for purposes of definitions
related to such provisions; provided further, that to the extent that the Code is used to define any term herein or in any Loan Document
and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article
or Division 9 shall govern.

 

     

     

    

 

“Collateral” has
the meaning assigned to it in Section 6.1.

 

“Contractual Obligation”
means as to any Person, any provision of any security issued by such Person or of any written agreement, instrument, or other undertaking
to which such Person is a party or by which it or any of its property is bound.

 

“Default”
means any Event of Default or any event that, with the passage of time or notice or both, would, unless cured or waived, become an Event
of Default.

 

“Default Rate” has the meaning assigned
to it in Section 1.4.

 

“Equity Purchase Agreement”
means the Securities Purchase Agreement dated as of February 3, 2022 between CRI and the purchasers named therein.

 

“Event of Default” has the meaning assigned
to it in Section 7.1.

 

“Financial Statements”
means the consolidated and consolidating income statement, balance sheet and statement of cash flows of Creative Realities, Inc. and of
Reflect Systems, Inc. prepared in accordance with GAAP.

 

“GAAP”
means generally accepted accounting principles in the United States of America as in effect from time to time, consistently applied.

 

“Governmental Authority”
means any nation or government, any state or other political subdivision thereof, and any agency, department or other entity exercising
executive, legislative, judicial, regulatory or administrative functions of or pertaining to government.

 

“Indebtedness”
of any Person means: (a) all indebtedness of such Person for borrowed money or for the deferred or unpaid purchase price of property or
services (including reimbursement and all other obligations with respect to surety bonds, letters of credit and bankers’ acceptances,
whether or not matured, but not including obligations to trade creditors incurred in the ordinary course of business and not more than
45 days past due); (b) all obligations evidenced by notes, bonds, debentures or similar instruments; (c) all indebtedness created or arising
under any conditional sale or other title-retention agreements with respect to property acquired by such Person (even though the rights
and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property);
(d) all capital lease obligations; (e) all guarantees of Indebtedness of other Persons; (f) all Indebtedness referred to in clauses (a),
(b), (c), (d) or (e) above that is secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise,
to be secured by) any Lien upon or in property (including accounts and contract rights) owned by such Person, even though such Person
has not assumed or become liable for the payment of such Indebtedness; (g) the Obligations; and (h) all liabilities under Title IV of
the Employee Retirement Income Security Act of 1974 (or any successor legislation thereto), as amended from time to time, and any regulations
promulgated thereunder.

 

“Intellectual Property”
means any and all Licenses, patents, copyrights, trademarks, trade secrets and customer lists.

 

“IRC” and
“IRS” mean respectively, the Internal Revenue Code of 1986 and the Internal Revenue Service, and any successors thereto.

 

     

     

    

 

“Lender”
means Slipstream Communications, LLC. and in the event of the assignment by Lender of any of its rights or obligations, shall mean the
assignee.

 

“License”
means any written agreement now owned or hereafter acquired by any Person granting any right with respect to (i) any copyright or copyright
registration, (ii) any invention on which a patent is in existence, (iii) the use of any trademark or trademark registration, or (iv)
other license of rights or interests now held or hereafter acquired by any Person.

 

“Lien”
means any mortgage, security deed or deed of trust, pledge, hypothecation, assignment, deposit arrangement, proxy, voting agreement, lien,
charge, claim, security interest, security title, easement or encumbrance, or preference, priority or other security agreement or preferential
arrangement of any kind or nature whatsoever (including any lease or title retention agreement, any financing lease having substantially
the same economic effect as any of the foregoing, and the filing of, or agreement to give, any financing statement perfecting a security
interest under the Code or comparable law of any jurisdiction).

 

“Litigation”
means any claim, lawsuit, litigation, investigation or proceeding of or before any arbitrator or Governmental Authority.

 

“Loan Documents”
means this Agreement, the Warrant and all security agreements and other documents, instruments, certificates, and notices at any time
delivered by any Person (other than Lender) in connection with any of the foregoing.

 

“Loan Rate”
means (i) with respect to the Consolidation Term Loan, a fixed rate equal to ten percent (10.0%) per annum; and (ii) with respect
to the 2022 Acquisition Term Loan, a fixed rate equal to eight percent (8.0%) per annum.

 

“Material Adverse
Effect” means any event, occurrence, fact, condition or change that is, or could reasonably be expected to become, individually
or in the aggregate, materially adverse to or have a material adverse effect on (a) the business, assets, operations, or financial or
other condition of Borrowers, (b) Borrower’s ability to pay or perform the Obligations under the Loan Documents in accordance with
the terms thereof, (c) the Collateral or Lender’s Liens on the Collateral or the priority of any such Lien, or (d) Lender’s
rights and remedies under this Agreement and the other Loan Documents.

 

“Maturity Date” means
February 17, 2025.

 

“Merger Agreement”
means the Agreement and Plan of Merger by and among Reflect, CRI, CRI Acquisition Corporation and RSI Exit Corporation dated as of November
12, 2021, as amended by an Amendment dated February 8, 2022..

 

“Minimum Actionable
Amount” means $100,000.

 

“Notes”
means, collectively, the Consolidation Term Note and the 2022 Acquisition Term Note.

 

“Obligations”
means all loans, advances, debts, expense reimbursement, fees, liabilities, and obligations for the performance of covenants, tasks or
duties or for payment of monetary amounts (whether or not such performance is then required or contingent, or amounts are liquidated or
determinable) owing by Borrowers to Lender, of any kind or nature, present or future, whether or not evidenced by any note, agreement
or other instrument, whether arising under any of the Loan Documents or under any other agreement between Borrowers and Lender, and all
covenants and duties regarding such amounts. This term includes all principal, interest (including interest accruing at the then-applicable
rate provided in this Agreement after the maturity of the Loans and interest accruing at the then-applicable Loan Rate after the filing
of any petition in bankruptcy, or the commencement of any insolvency, reorganization or like proceeding, whether or not a claim for post-filing
or post-petition interest is allowed in such proceeding), fees, Charges, expenses, attorneys’ fees and any other sum chargeable
to Borrowers under any of the Loan Documents, and all principal and interest due in respect of the Loans.

 

     

     

    

 

“Permitted Encumbrances”
means the following encumbrances: (a) Liens for Taxes or assessments or other charges or levies, either not yet due or payable; (b) pledges
or deposits securing obligations under worker’s compensation, unemployment insurance, social security or public liability laws or
similar legislation; (c) pledges or deposits securing bids, tenders, contracts (other than contracts for the payment of money) or leases
to which any Borrower is a party as lessee made in the ordinary course of business in an aggregate amount outstanding at any time not
in excess of $75,000; (d) deposits securing public or statutory obligations of Borrower; (e) inchoate and unperfected workers’,
mechanics’, or similar liens arising in the ordinary course of business so long as such Liens attach only to Equipment, fixtures
or real estate; (f) carriers’, warehousemans’, suppliers’ or other similar possessory liens arising in the ordinary
course of business and securing indebtedness not yet due and payable in an outstanding aggregate amount not in excess of $75,000 at any
time so long as such Liens attach only to Inventory; (g) deposits of money securing, or in lieu of, surety, appeal or customs bonds in
proceedings to which any Borrower is a party; (h) zoning restrictions, easements, licenses, or other restrictions on the use of real property
or other minor irregularities in title (including leasehold title) thereto, so long as the same do not materially impair the use, value,
or marketability of such real estate; (i) Purchase Money Liens securing Purchase Money Indebtedness (or rent) to the extent permitted
under Section 5(b); (j) all of those Liens in existence on the Closing Date and disclosed on Disclosure Schedule 5(d) in the amounts
and on the terms set forth on said schedule; and (k) Liens in favor of Lender securing the Obligations.

 

“Person”
means any individual, sole proprietorship, partnership, limited liability partnership, joint venture, trust, unincorporated organization,
association, corporation, limited liability company, institution, public benefit corporation, entity or government (whether domestic or
foreign, federal, state, county, city, municipal or otherwise, including any instrumentality, division, agency, body or department thereof),
and shall include such Person’s successors and assigns.

 

“PPSA”
means the Personal Property Security Act of the province of Ontario.

 

“Purchase Money Indebtedness”
means (a) any Indebtedness incurred for the payment of all or any part of the purchase price of any fixed asset, (b) any Indebtedness
incurred for the sole purpose of financing or refinancing all or any part of the purchase price of any fixed asset, and (c) any renewals,
extensions or refinancings thereof.

 

“Purchase Money Lien”
means any Lien upon any fixed assets which secures the Purchase Money Indebtedness related thereto, but only if such Lien shall at all
times be confined solely to the asset the purchase price of which was financed or refinanced through the incurrence of the Purchase Money
Indebtedness secured by such Lien and only if such Lien secures only such Purchase Money Indebtedness.

 

“Real Property”
has the meaning assigned to it in Section 3.6.

 

“Reflect Note”
means that certain Note and Security Agreement, dated February 17, 2022, made by CRI and Reflect payable to the order of RSI Exit Corporation.

 

“Requirement of Law”
means as to any Person, the Articles of Incorporation and Bylaws or other organizational or governing documents of such Person, and any
law, treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case binding upon
such Person or any of its property or to which such Person or any of its property is subject.

 

     

     

    

 

“Restricted Payment”
means: (a) the declaration or payment of any cash dividend or the incurrence of any liability to make any other payment or distribution
of cash or other property or assets on or in respect of Borrower’s capital stock; (b) any payment or distribution made in respect
of any subordinated Indebtedness of Borrowers in violation of any subordination or other agreement made in favor of Lender; (c) any prepayment
on account of the Reflect Note; and (d) any payment on account of the purchase, redemption, defeasance or other retirement of Borrower’s
capital stock or any other payment or distribution made in respect of any thereof, either directly or indirectly; provided, however,
that no payment to Lender shall constitute a Restricted Payment.

 

“Taxes”
means taxes, levies, imposts, deductions, Charges or withholdings, and all liabilities with respect thereto, excluding taxes imposed on
or measured by the net income of Lender.

 

“Termination Date”
means the date on which all Obligations under this Agreement are indefeasibly paid in full, in cash, and Borrowers shall have no further
right to borrow any moneys or obtain other credit extensions or financial accommodations under this Agreement.

 

“Warrants”
means the Warrants issued by CRI to Lender set forth on Schedule B hereto, including but not limited to Warrant issued by
CRI to Lender in connection with this Agreement (in substantially the form attached hereto as Exhibit A), or the Existing
Agreement and any amendment to the Existing Agreement, including the Warrant dated on or about August 17, 2016, the Warrant dated November
13, 2017, the Warrant dated January 6, 2018 and the Warrant dated April 27, 2018, and any replacements or substitutions thereof.

 

Any accounting
term used in this Agreement or the other Loan Documents shall have, unless otherwise specifically provided therein, the meaning customarily
given such term in accordance with GAAP, and all financial computations thereunder shall be computed, unless otherwise specifically provided
therein, in accordance with GAAP consistently applied. All capitalized terms used in this Agreement or other Loan Documents but undefined
shall, unless the context indicates otherwise, have the meanings provided for by the Code. The words “herein,” “hereof’
and “hereunder” or other words of similar import refer to this Agreement as a whole, including the exhibits and schedules
thereto, as the same may from time to time be amended, modified or supplemented, and not to any particular section, subsection or clause
contained in this Agreement.

 

For purposes of
this Agreement and the other Loan Documents, the following additional rules of construction shall apply, unless specifically indicated
to the contrary: (a) wherever from the context it appears appropriate, each term stated in either the singular or plural shall include
the singular and the plural; (b) the term “or” is not exclusive; (c) the term “including” (or any form thereof)
shall not be limiting or exclusive; (d) all references to statutes and related regulations shall include any amendments of same and any
successor statutes and regulations; and (e) all references to any instruments or agreements, including references to any of the Loan Documents,
shall include any and all modifications or amendments thereto and any and all extensions or renewals thereof.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}]]